Dosing of factor VIII concentrate by ideal body weight is more accurate in overweight and obese haemophilia A patients

AIMS: Under‐ and, especially, overdosing of replacement therapy in haemophilia A patients may be prevented by application of other morphometric variables than body weight (BW) to dose factor VIII (FVIII) concentrates. Therefore, we aimed to investigate which morphometric variables best describe inte...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Br J Clin Pharmacol
Main Authors: van Moort, Iris, Preijers, Tim, Hazendonk, Hendrika C.A.M., Schutgens, Roger E.G., Laros‐van Gorkom, Britta A.P., Nieuwenhuizen, Laurens, van der Meer, Felix J.M., Fijnvandraat, Karin, Leebeek, Frank W.G., Meijer, Karina, Mathôt, Ron A.A., Cnossen, Marjon H.
Formato: Artigo
Idioma:Inglês
Publicado em: John Wiley and Sons Inc. 2020
Assuntos:
Original Articles
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC8246536/
https://ncbi.nlm.nih.gov/pubmed/33232535
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/bcp.14670
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados